Search Results 1061-1070 of 18043 for Alcoholics

1. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

   Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The ...

3. A Study Comparing Either Cervical Spine, Head, Temporal Bone or Vasculature Treated with Metallic Implants Imaged with CT or MRI or Cerebral Angiogram to a MRI Zero Echo Time (ZTE) MRI Sequence - Mayo Clinic

   A Study Comparing Either Cervical Spine, Head, Temporal Bone or Vasculature Treated with Metallic Implants Imaged with CT or MRI or Cerebral Angiogram to a MRI ...

4. Nutrition and healthy eating Resources - Mayo Clinic

   Healthy diets · Includes a variety of foods from the major food groups: fruits; vegetables; whole grains; low-fat dairy products and lean protein, including ...

5. Cholecystectomy (gallbladder removal) - Doctors & Departments - Mayo Clinic

   ... Alcoholic liver disease, Portal hypertension, Chronic liver disease, Budd-Chiari syndrome, Metabolic liver disease, Polycystic liver disease. Show more areas ...

6. Opioid Use After PCNL - Clinical Trials

   About this study. The purpose of the study is to assess patients' use of opioid and non-opioid pain medication following percutaneous nephrolithotomy, ...

7. The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy - Mayo Clinic

   The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...

8. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

   A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

9. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

   About this study. The purpose of this study is to assess the safety, tolerability, movement (pharmcokinetics, "PK"), biological response (pharmacodynamics, ...

10. Hepatitis B - Doctors and departments - Mayo Clinic

    This contagious liver infection can be long lasting. Learn how the infection spreads and what you can do to prevent or treat it.